Skip to main content
Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.
Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
Genetic disorders of lung development.
Large Scale Next Generation Sequencing and Newborn Screening: Are We Ready?
50 Years Ago in The Journal of Pediatrics: Radiologic Findings in the Lungs of Premature Infants.
Challenges of Funding Pediatric Fellowship Programs-Invited Commentary from the Council of Pediatric Subspecialties.
Turning a negative into a positive.